AR112530A1 - PHARMACEUTICAL COMPOSITIONS OF AJOENO OR AN ANALOGUE OR DERIVATIVE THEREOF AND ITS USES - Google Patents
PHARMACEUTICAL COMPOSITIONS OF AJOENO OR AN ANALOGUE OR DERIVATIVE THEREOF AND ITS USESInfo
- Publication number
- AR112530A1 AR112530A1 ARP180102443A AR112530A1 AR 112530 A1 AR112530 A1 AR 112530A1 AR P180102443 A ARP180102443 A AR P180102443A AR 112530 A1 AR112530 A1 AR 112530A1
- Authority
- AR
- Argentina
- Prior art keywords
- derivative
- ajoeno
- analogue
- pharmaceutical compositions
- ajoene
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- IXELFRRANAOWSF-FNORWQNLSA-N (E)-Ajoene Chemical compound C=CCSS\C=C\CS(=O)CC=C IXELFRRANAOWSF-FNORWQNLSA-N 0.000 abstract 2
- 238000010521 absorption reaction Methods 0.000 abstract 2
- IXELFRRANAOWSF-CYBMUJFWSA-N ajoene Natural products C=CCSSC=CC[S@](=O)CC=C IXELFRRANAOWSF-CYBMUJFWSA-N 0.000 abstract 2
- IXELFRRANAOWSF-UHFFFAOYSA-N cis-ajoene Natural products C=CCSSC=CCS(=O)CC=C IXELFRRANAOWSF-UHFFFAOYSA-N 0.000 abstract 2
- 229910001415 sodium ion Inorganic materials 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/105—Persulfides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Reivindicación 1: Una composición farmacéutica que comprende ajoeno, o un análogo o un derivado de éste, caracterizada porque es para usar en una terapia para disminuir la absorción de iones de sodio en las células. Reivindicación 33: Un método para disminuir la absorción de iones de sodio en las células caracterizado porque comprende administrar una composición farmacéutica que comprende ajoeno o un análogo o un derivado de éste.Claim 1: A pharmaceutical composition comprising ajoene, or an analog or a derivative thereof, characterized in that it is for use in a therapy to decrease the absorption of sodium ions in cells. Claim 33: A method to decrease the absorption of sodium ions in cells characterized in that it comprises administering a pharmaceutical composition comprising ajoene or an analog or a derivative thereof.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1713920.5A GB201713920D0 (en) | 2017-08-30 | 2017-08-30 | Pharmaceutical compositions and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR112530A1 true AR112530A1 (en) | 2019-11-06 |
Family
ID=60037264
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP180102443 AR112530A1 (en) | 2017-08-30 | 2018-08-28 | PHARMACEUTICAL COMPOSITIONS OF AJOENO OR AN ANALOGUE OR DERIVATIVE THEREOF AND ITS USES |
Country Status (4)
| Country | Link |
|---|---|
| AR (1) | AR112530A1 (en) |
| GB (1) | GB201713920D0 (en) |
| TW (1) | TW201919593A (en) |
| WO (1) | WO2019043375A1 (en) |
-
2017
- 2017-08-30 GB GBGB1713920.5A patent/GB201713920D0/en not_active Ceased
-
2018
- 2018-08-28 AR ARP180102443 patent/AR112530A1/en unknown
- 2018-08-29 WO PCT/GB2018/052432 patent/WO2019043375A1/en not_active Ceased
- 2018-08-29 TW TW107130155A patent/TW201919593A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2019043375A1 (en) | 2019-03-07 |
| GB201713920D0 (en) | 2017-10-11 |
| TW201919593A (en) | 2019-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2019006291A2 (en) | Amino acid compositions and methods of treatment of liver diseases | |
| DOP2019000005A (en) | 3-METIL PIRAZINAS 2,5-DISUSTITUIDAS AND 3-METIL PIRAZINAS 2,5,6-TRISUSTITUIDAS AS ALLOSTERIC INHIBITORS OF SHP2 | |
| CL2020000122A1 (en) | Treatment methods for cystic fibrosis. | |
| MX2019005379A (en) | Pyrazolo-heteroaryl derivative, preparation method and medical use thereof. | |
| CL2020000220A1 (en) | Compositions comprising amino acids for use in the treatment of diseases related to mitochondrial dysfunction. | |
| MX2020005841A (en) | 1,2,4-oxadiazole derivatives as histone deacetylase 6 inhibitors. | |
| MX2017010220A (en) | FORMULATIONS FOR ORAL ADMINISTRATION OF ACTIVE AGENTS WITH CONTROLLED ABSORPTION PROFILE. | |
| BR112016020199A8 (en) | human plasma kallikrein inhibitor compound, pharmaceutical composition comprising said compound, kit and its use | |
| MX2023001963A (en) | HYPERTONIC PHARMACEUTICAL COMPOSITIONS CONTAINING AN ANTIPLATIN CHEMOPPROTECTIVE AGENT. | |
| BR112016004358A8 (en) | pharmaceutical combination of an alk inhibitor and a cdk inhibitor for the treatment of cell proliferative diseases, pharmaceutical composition, their uses, and kit | |
| CL2011002675A1 (en) | Use of compounds derived from 9-purin-9-yl-3,4-dihydroxytetrahydrofuran-2-yl-methyl nitrate or sulfate to reduce intraocular pressure; ophthalmic pharmaceutical composition comprising the compounds; and ophthalmic formulation of topical use that includes them. | |
| CL2019002218A1 (en) | Triple combination formulations and methods to treat or reduce the risk of cardiovascular disease. | |
| MX2017011499A (en) | FIXED DOSE COMBINATIONS AND FORMULATIONS THAT INCLUDE ACID 8-HIDROXI-2,2,14,14 TETRAMETILPENTADECANODIOICO (ETC1002) AND EZETIMIBE AND METHODS TO TREAT OR REDUCE THE RISK OF CARDIOVASCULAR DISEASE. | |
| CL2020000221A1 (en) | Compositions comprising amino acids for use in the treatment of diseases related to mitochondrial dysfunction. | |
| MX2018000264A (en) | TOPICAL FORMULATIONS OF DIHEREIN OF RHEINA AND ITS USES. | |
| CO2019009020A2 (en) | Pyrazole derivatives as bromodomain inhibitors. | |
| UY37729A (en) | NEW COMPOUNDS THAT INHIBIT THE ACTIVITY OF Nav1.7 | |
| BR112021011368A2 (en) | Ketoprofen cocrystal, compositions comprising the same, process for their production and uses thereof | |
| MX2022014577A (en) | LEVODOPA AND CARBIDOPA INTESTINAL GEL AND METHODS OF USE. | |
| ECSP16005208A (en) | STABLE ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION IN A FORM OF A COATED TABLET INCLUDING ISONIAZID GRANULES AND RIFAPENTINE GRANULES AND THEIR PREPARATION PROCESS | |
| MX381932B (en) | INTRANASAL COMPOSITION INCLUDING BETAHISTINE. | |
| MX389461B (en) | Compositions comprising a polysaccharide matrix for the controlled release of active ingredients | |
| AR112530A1 (en) | PHARMACEUTICAL COMPOSITIONS OF AJOENO OR AN ANALOGUE OR DERIVATIVE THEREOF AND ITS USES | |
| CL2019002020A1 (en) | A pharmaceutical composition comprising an oxazine derivative and its use in the treatment or prevention of Alzheimer's disease. | |
| BR112019017314A2 (en) | pharmaceutical compositions for combination therapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |